Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/2008
12/02/2008US7459164 Composition for therapeutic and cosmetic botulinum toxin
12/02/2008US7459156 Antibodies that mimic actions of neurotrophins
12/02/2008US7459155 Administering aspartic acid peptidases, thiol peptidases, metallopeptidases, serine peptidases, threonine peptidases, alkaline peptidases, semi-alkaline peptidases, neutral proteases or mixtures for treating pain of chronic or acute pancreatitis or related conditions
12/02/2008US7459143 Monoclonal antibodies; determination blood coagulation; dissolving clots; administering deimmunized immunointeractive molecules; using planar or computer assisted tomographic nuclear medicine scan to visualize a clot
12/02/2008US7458982 Photokinetic delivery of biologically active substances using pulsed incoherent light
12/02/2008CA2409771C Method of use of peptide antagonists of zonulin to prevent or delay the onset of diabetes
12/02/2008CA2397404C Micronized freeze-dried particles
12/02/2008CA2341624C Stable spray-dried protein formulations
12/02/2008CA2303395C Treatment of obesity
12/02/2008CA2282843C Purification of von willebrand factor by cation exchange chromatography
12/02/2008CA2282841C A method of purifying factor viii/vwf-complex by means of cation exchange chromatography
12/02/2008CA2267671C Method for manufacturing expanded hematopoietic cells with stem cell factor polypeptide
12/02/2008CA2265484C Tumor homing molecules, conjugates derived therefrom, and methods of using same
12/02/2008CA2241918C Peanut allergens and methods
12/02/2008CA2226400C Human complementarity determining region (cdr) - grafted antibody to ganglioside gm2
12/02/2008CA2140538C Monoclonal antibodies that block ligand binding to the cd22 receptor in mature b cells
12/02/2008CA2136434C Erythropoietin drug delivery system
12/02/2008CA2120527C Helicobacter pylori genes necessary for the regulation and the maturation of urease and their use
12/01/2008CA2590593A1 Mutated hoxb4 proteins with improved stability, and methods of use thereof
11/2008
11/30/2008CA2594214A1 Pharmaceutical compositions comprising unacylated ghrelin and therapeutical uses thereof
11/27/2008WO2008144754A2 Methods of treating inflammatory disorders using isoforms of receptor tyrosine kinases
11/27/2008WO2008144720A2 Inhibitors of igf-1r signaling for the treatment of respiratory disorders
11/27/2008WO2008144690A2 Compositions and methods for enhancing active agent absorption
11/27/2008WO2008144590A2 Long lasting modified antifusogenic peptide for preventing hiv infection
11/27/2008WO2008144543A2 Compositions and methods for establishing and/or maintaining pregnancy
11/27/2008WO2008144506A1 Apoptotic pathway targeting for the diagnosis and treatment of cancer
11/27/2008WO2008144500A2 1-methyl-benzo[1,2,4]thiadiazine, 1-oxide derivatives
11/27/2008WO2008144351A2 Compositions and methods for inhibiting inducible t cell kinase (itk) and treating asthma and bronchial inflammations
11/27/2008WO2008144072A1 Dose forms comprising vx- 950 and their dosage regimen
11/27/2008WO2008144019A2 Suppression of allergic inflammation by ascaris heme-binding protein (hbp)
11/27/2008WO2008143996A1 New chemical processes
11/27/2008WO2008143958A1 Use of somatostatin analogs in myocardial perfusion imaging
11/27/2008WO2008143947A1 Farnesylamine derivatives and methods of use
11/27/2008WO2008143867A1 Concentrated protein preparations of bone morphogenetic proteins and methods of use thereof
11/27/2008WO2008143835A1 Ghrelin protects substantia nigra dopamine neurons
11/27/2008WO2008143824A1 Treatment of allergic disease with immunomodulator compounds
11/27/2008WO2008143816A1 Compositions and methods for reducing friction between the surface of tendons or other soft tissues
11/27/2008WO2008143812A2 Biologic devices for hemostasis
11/27/2008WO2008143681A1 Methods for identifying areas of a subject's skin that appear to lack volume
11/27/2008WO2008143680A1 Methods for indentifying areas of a subject's skin that appear to lack volume
11/27/2008WO2008143594A1 Hypoallergenic polypeptides
11/27/2008WO2008143354A1 Pharmaceutical composition for enzyme replacement therapy
11/27/2008WO2008143339A1 Amphipathic molecule, molecular aggregate comprising the amphipathic molecule, and use of the molecular aggregate
11/27/2008WO2008143280A1 Sedative agent
11/27/2008WO2008143151A1 Therapeutic agent and detection reagent for arteriosclerotic disease which targets for thallusin
11/27/2008WO2008142693A2 Regulation of myelination by nectin-like (necl) molecules
11/27/2008WO2008142319A2 Peptide analogues of melanocortin receptors
11/27/2008WO2008142194A1 Method for the in vitro diagnosis/prognosis of huntington's chorea
11/27/2008WO2008142153A1 An extended-release composition comprising a somatostatin derivative in microparticles
11/27/2008WO2008142124A1 Recombinant protein production in avian ebx® cells
11/27/2008WO2008142102A2 Use of transferrin for preparing pharmaceutical compositions useful for treating bacterial infections as coadjuvants in antibiotic therapy
11/27/2008WO2008141786A2 Peptides having the biological activity of vasoactive intestinal peptide (vip) and their use for the treatment of lung diseases
11/27/2008WO2008141496A1 Sustained-release system for epo and gm-csf
11/27/2008WO2008141480A1 Human angiostatin interacting and tumor metastasis involving protein variants and uses thereof
11/27/2008WO2008114577A3 Antibacterial peptide
11/27/2008WO2008104000A3 Triazole macrocycle systems
11/27/2008WO2008100458A3 Method of treating or preventing tissue deterioration, injury or damage due to disease of mucosa
11/27/2008WO2008085578A3 Anti-microbial compositions and devices and methods of using the same
11/27/2008WO2008082563A3 Sustained-release formulations comprising crystals, macromolecular gels, and particulate suspensions of biologic agents
11/27/2008WO2008079976A3 Dimeric high affinity egfr constructs and uses thereof
11/27/2008WO2008079566A3 Compositions and methods of modulating cell growth and motility
11/27/2008WO2008076806A3 Compositions and methods to potentiate colistin activity
11/27/2008WO2008073351A3 Uses of cerberus, coco and derivatives thereof
11/27/2008WO2008073162A3 Lysine acetylation sites
11/27/2008WO2008071438A3 Treatment of disease or injury of the nervous system using agents that decrease the activity of the melanocortin 4 receptor
11/27/2008WO2008066744A3 Methods and compositions for treating and preventing spinal cord injury and other neuronal disease or injury
11/27/2008WO2008066715A3 Method of treatment using aspergillus oryzae protease
11/27/2008WO2008063849A3 Multiple sclerosis therapy
11/27/2008WO2008061014A9 Self-assembling peptide amphiphiles for tissue engineering
11/27/2008WO2008060622A9 Improved methods and compositions for wound healing
11/27/2008WO2008051505A3 Protease resistant mutants of stromal cell derived factor-1 in the repair of tissue damage
11/27/2008WO2008045970A3 Compositions and methods of using chondroitinase abci mutants
11/27/2008WO2008032153A3 Calreticulin for its use as a medication for the treatment of cancer in a mammal
11/27/2008WO2008030988A3 Selectively targeted antimicrobial peptides and the use thereof
11/27/2008WO2008022030A3 Promiscuous pap cd4 t cell epitopes
11/27/2008WO2008021987A3 Proteolytic enzyme formulations
11/27/2008WO2008011193A3 Bmp-1 procollagen c-proteinase for diagnosis and treatment of bone and soft tissue defects and disorders
11/27/2008WO2008008373A3 Rhinosinusitis prevention and therapy with proinflammatory cytokine inhibitors
11/27/2008WO2008005290A3 Methods for testing anti-thrombotic agents
11/27/2008WO2007149288A3 C1-inhibitor prevents non-specific plasminogen activation by a prourokinase mutant without impeding fibrin-specific fibrinolysis
11/27/2008WO2007143582A3 Reversal of the suppressive function of specific t cells via toll-like receptor 8 signaling
11/27/2008WO2007138339A3 Treatment of pain by use of a single chain polypeptide fusion protein
11/27/2008WO2007126847A3 Coadministration of alpha-fetoprotein and a disease modifying anti-rheumatic drug for treating inflammatory arthritic disease
11/27/2008WO2007123848A3 Therapeutic compositions containing modified class i slrp proteins
11/27/2008WO2007112453A3 Methods amd compositions for treating conditions
11/27/2008WO2007104062A3 Compositions and methods based on peptide binding profiling
11/27/2008WO2007101106A3 Compositions and methods for modulating hemostasis using variant forms of activated factor v
11/27/2008WO2007101103A3 Compositions and assays for inhibiting hcv infection
11/27/2008WO2007100775A3 Methods for regulating neurotransmitter systems by inducing counteradaptations
11/27/2008WO2007100622A3 Variably crosslinked tissue
11/27/2008WO2007084743A3 Intraventricular protein delivery for amyotrophic lateral sclerosis
11/27/2008WO2007070562A3 Non-hygroscopic compositions of enterostatin
11/27/2008WO2007021822A3 Compositions and methods of preparation of liposomal microparticulate il-12
11/27/2008WO2005116235A8 Endothelial cell apoptosis induced by fibrinogen gamma chain c-terminal fragment
11/27/2008WO2005112981A3 Compositions and methods for the stimulation or enhancement of bone formation and the self-renewal of cells
11/27/2008WO2004112726A3 Methods and compositions for controlling appetite and modulating insulin sensitivity
11/27/2008US20080293962 Novel compounds of the N-acylamino amide family compositions comprising them and uses thereof
11/27/2008US20080293924 Process For the Isolation and/or Purification of Proteins
11/27/2008US20080293727 Amine hydroxyalkyl sulfonamides as enzyme inhibitors; for example, N-1-(3-((3-acetylamino-4-fluoro-benzenesulfonyl)-benzyl-amino)-(1S,2 syn)-1-benzyl-2-hydroxy-propyl)-2-((quinoline-2-carbonyl)-amino)-succinamide; may be used as anti-viral agents against the HIV-1 and HIV-2 viruses
11/27/2008US20080293668 [5-carboxamido or 5-fluoro]-[2',3'-unsaturated or 3'-modified]-pyrimidine nucleosides
1 ... 863 864 865 866 867 868 869 870 871 872 873 874 875 876 877 878 879 880 881 882 883 ... 3163